{"id":"https://openalex.org/W2592572504","doi":"https://doi.org/10.1158/1538-7445.sabcs16-p3-03-07","title":"Abstract P3-03-07: High-throughput pharmacogenomic platform to functionally probe breast cancer vulnerabilities in the context of the 3-dimensional tumor microenvironment","display_name":"Abstract P3-03-07: High-throughput pharmacogenomic platform to functionally probe breast cancer vulnerabilities in the context of the 3-dimensional tumor microenvironment","publication_year":2017,"publication_date":"2017-02-15","ids":{"openalex":"https://openalex.org/W2592572504","doi":"https://doi.org/10.1158/1538-7445.sabcs16-p3-03-07","mag":"2592572504"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs16-p3-03-07","doi":"https://doi.org/10.1158/1538-7445.sabcs16-p3-03-07","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs16-p3-03-07","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074250265","display_name":"Eugen Dhimolea","orcid":"https://orcid.org/0000-0002-8445-5509","observed_orcids":["https://orcid.org/0000-0002-8445-5509"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E Dhimolea","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005661878","display_name":"Ricardo De Matos Simoes","orcid":"https://orcid.org/0000-0002-1700-5276","observed_orcids":["https://orcid.org/0000-0002-1700-5276"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R De Matos Simoes","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030243364","display_name":"Pallavi Awate","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P Awate","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100666803","display_name":"Huihui Tang","orcid":"https://orcid.org/0000-0003-2580-4016","observed_orcids":["https://orcid.org/0000-0003-2580-4016"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H Tang","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082180580","display_name":"Aed\u00edn C. Culhane","orcid":"https://orcid.org/0000-0002-1395-9734","observed_orcids":["https://orcid.org/0000-0002-1395-9734"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Culhane","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012712111","display_name":"Constantine S. Mitsiades","orcid":"https://orcid.org/0000-0003-2321-8005","observed_orcids":["https://orcid.org/0000-0003-2321-8005"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C Mitsiades","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"4_Supplement","first_page":"P3","last_page":"03"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.8901000022888184,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.8901000022888184,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.04410000145435333,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11190","display_name":"3D Printing in Biomedical Research","score":0.010700000450015068,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9810000061988831},{"id":"https://openalex.org/keywords/3d-tumor-microenvironment","display_name":"3D tumor microenvironment","score":0.8740000128746033},{"id":"https://openalex.org/keywords/tumor-spheroids","display_name":"tumor spheroids","score":0.8510000109672546},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.8500000238418579},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/antiestrogens","display_name":"antiestrogens","score":0.6840000152587891},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6980000138282776},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.7020000219345093},{"id":"https://openalex.org/keywords/pharmacogenomics","display_name":"pharmacogenomics","score":0.5019999742507935},{"id":"https://openalex.org/keywords/high-throughput-drug-screening","display_name":"high-throughput drug screening","score":0.703000009059906},{"id":"https://openalex.org/keywords/mesenchymal-stem-cells","display_name":"mesenchymal stem cells","score":0.8220000267028809},{"id":"https://openalex.org/keywords/folate-metabolism","display_name":"folate metabolism","score":0.7549999952316284},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.7910000085830688},{"id":"https://openalex.org/keywords/antifolate-drugs","display_name":"antifolate","score":0.6930000185966492},{"id":"https://openalex.org/keywords/anthracyclines","display_name":"anthracyclines","score":0.8230000138282776},{"id":"https://openalex.org/keywords/vinca-alkaloids","display_name":"vinca alkaloids","score":0.8880000114440918},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.8190000057220459}],"concepts":[{"id":"https://openalex.org/C175369904","wikidata":"https://www.wikidata.org/wiki/Q208395","display_name":"Spheroid","level":3,"score":0.7003106474876404},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6686863303184509},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.6088752746582031},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5783362984657288},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.5183926224708557},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5028221011161804},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4918103516101837},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4907613694667816},{"id":"https://openalex.org/C2778608917","wikidata":"https://www.wikidata.org/wiki/Q6787805","display_name":"Matrigel","level":3,"score":0.4666248559951782},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.45101597905158997},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.4460844397544861},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.41931888461112976},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4088286757469177},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3468588590621948},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3377988934516907},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3220646381378174},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.29744765162467957},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2377912700176239},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22720852494239807},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.1356198787689209},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs16-p3-03-07","doi":"https://doi.org/10.1158/1538-7445.sabcs16-p3-03-07","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs16-p3-03-07","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2059755711","https://openalex.org/W2566233864","https://openalex.org/W2740044761","https://openalex.org/W2093094192","https://openalex.org/W2811274708","https://openalex.org/W1980324695","https://openalex.org/W2792523292","https://openalex.org/W339117501","https://openalex.org/W3034520649","https://openalex.org/W2022698864"],"abstract_inverted_index":{"Abstract":[0],"The":[1,77,192],"pharmacological":[2,161],"vulnerabilities":[3,188,389,445],"of":[4,14,105,116,122,128,141,149,163,178,204,207,255,261,268,292,299,312,321,336,399,449,457],"malignant":[5,27,59,322,400],"cells":[6,52,80,96,130,151,271,314,323],"have":[7],"been":[8],"traditionally":[9],"evaluated":[10],"by":[11,102,372],"the":[12,55,58,94,112,138,147,175,202,242,249,296,369,387,397,447,450,458],"use":[13],"cell":[15,245],"lines":[16],"grown":[17,85],"in":[18,20,29,61,86,92,111,126,180,189,201,301,315,349,381,391,405,446],"vitro":[19,181],"2-dimensional":[21],"(2D)":[22],"plastic":[23],"surfaces.":[24],"In":[25],"contrast,":[26],"tumors":[28],"vivo":[30],"grow":[31],"as":[32,220,222,324],"3-dimensional":[33,139,451],"(3D)":[34],"cellular":[35],"masses.":[36],"We":[37,155,343],"used":[38],"Estrogen":[39],"Receptor":[40],"(ER)-positive":[41],"(MCF7,":[42],"ZR75-1":[43],"and":[44,46,72,168,183,212,307,334,351,355,359,394,402,413],"T47D)":[45],"triple-negative":[47,243],"(MDA-MB-231)":[48],"breast":[49,443],"cancer":[50,444],"(BrCa)":[51],"to":[53,68,74,152,173,184,248,286,331,376,385,395,440],"assess":[54,174],"differences":[56],"between":[57],"growth":[60,277,320,401],"2D":[62,353,392],"vs.":[63,236],"3D":[64,190,193,232,276,282,302,325,383,406],"conditions":[65,393],"with":[66,131,198,329],"regards":[67],"morphology,":[69],"molecular":[70,374],"characteristics":[71],"response":[73],"therapeutic":[75,416],"agents.":[76,154],"ER-positive":[78,117,250,262,269],"BrCa":[79,118,129,150,187,251,263,313,362],"formed":[81],"compact":[82,113],"spheroids":[83,283,326],"when":[84],"collagen":[87],"type":[88],"I":[89],"or":[90],"matrigel;":[91],"contrast":[93],"MDA-MB-231":[95,244],"assumed":[97],"an":[98],"invasive":[99],"phenotype":[100],"characterized":[101],"infiltrating":[103],"bundles":[104],"cells.":[106,119,252],"Antiestrogens":[107],"induced":[108,258],"acinar":[109],"differentiation":[110],"spheroid":[114,194],"morphology":[115,195],"This":[120,230,408],"effect":[121,298],"antiestrogens":[123],"was":[124,196,238,327],"blocked":[125],"co-cultures":[127],"bone":[132],"marrow":[133],"stromal":[134],"cells,":[135],"suggesting":[136,288],"that":[137,319],"microenvironment":[140,453],"distant":[142],"metastatic":[143],"sites":[144],"can":[145,410],"affect":[146],"susceptibility":[148],"anti-tumor":[153],"further":[156],"probed":[157],"this":[158,273,316],"question":[159],"through":[160],"screens":[162,380],"~100":[164],"FDA-approved":[165],"antineoplastic":[166],"agents":[167],"400":[169],"target-annotated":[170],"kinase":[171,228],"inhibitors,":[172,219],"pathophysiological":[176],"relevance":[177],"these":[179,373],"interactions":[182],"identify":[185],"specific":[186],"conditions.":[191,278,303,407],"associated":[197,328],"significant":[199],"decrease":[200],"efficacy":[203],"several":[205,357],"classes":[206],"conventional":[208],"DNA-damaging":[209],"(e.g.":[210,214,339],"anthracyclins)":[211],"anti-microtubule":[213],"vinca":[215],"alkaloids)":[216],"agents,":[217],"proteasome":[218],"well":[221],"recently":[223],"established":[224],"targeted":[225],"therapies,":[226],"includding":[227],"inhibitors.":[229],"differential":[231],"spheroid-associated":[233],"drug":[234,403],"resistance":[235,404],"sensitization":[237],"more":[239],"pronounced":[240],"for":[241,295,418],"line":[246],"compared":[247],"Interestingly,":[253,279],"inhibition":[254],"folate":[256],"metabolism":[257,333],"reduced":[259],"viability":[260],"spheroids,":[264],"indicating":[265],"increased":[266],"dependency":[267],"tumor":[270,452],"on":[272],"pathway,":[274],"under":[275],"mut-p53":[280],"T47D":[281],"were":[284],"resistant":[285],"antifolates,":[287],"a":[289,345],"possible":[290],"role":[291],"functional":[293],"p53":[294],"anti-BrCa":[297],"antifolates":[300],"Gene":[304],"expression":[305],"analysis":[306,375],"reverse-phase":[308],"protein":[309],"array":[310],"analyses":[311],"system":[317],"indicated":[318],"switch":[330],"glycolysis":[332],"up-regulation":[335],"survival":[337],"signals":[338],"Mcl1,":[340],"Hsp70":[341],"et.c.).":[342],"conducted":[344],"genome-wide":[346],"CRISPR":[347,379],"screen":[348],"MCF7":[350],"MDAMB231":[352],"cultures":[354],"identified":[356],"known":[358],"previously":[360,414],"underappreciated":[361,415],"essential":[363],"genes;":[364],"we":[365],"are":[366],"currently":[367],"using":[368],"insight":[370],"obtained":[371],"conduct":[377],"focused":[378],"our":[382],"cultures,":[384],"validate":[386],"genetic":[388],"observed":[390],"determine":[396],"mediators":[398],"approach":[409],"reveal":[411],"novel":[412],"targets":[417],"drug-resistant":[419],"BrCa.":[420],"Citation":[421],"Format:":[422],"Dhimolea":[423],"E,":[424],"De":[425],"Matos":[426],"Simoes":[427],"R,":[428],"Awate":[429],"P,":[430],"Tang":[431],"H,":[432],"Culhane":[433],"A,":[434],"Mitsiades":[435],"C.":[436],"High-throughput":[437],"pharmacogenomic":[438],"platform":[439],"functionally":[441],"probe":[442],"context":[448],"[abstract].":[454],"In:":[455],"Proceedings":[456],"2016":[459,465],"San":[460,468],"Antonio":[461],"Breast":[462],"Cancer":[463,474],"Symposium;":[464],"Dec":[466],"6-10;":[467],"Antonio,":[469],"TX.":[470],"Philadelphia":[471],"(PA):":[472],"AACR;":[473],"Res":[475],"2017;77(4":[476],"Suppl):Abstract":[477],"nr":[478],"P3-03-07.":[479]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2017-03-16T00:00:00"}